Related Experiment Videos
Fibroblasts and dermal gene therapy: a minireview
1Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA. krueger@derm.med.utah.edu
Human Gene Therapy
|November 21, 2000
Summary
Genetically modified fibroblasts (GMFb) show enhanced survival and transgene expression in vivo with matrix scaffolding, extracellular matrix components, and immortalized cells. These advancements support GMFb as a promising tool for gene therapy applications.
Area of Science:
- Biotechnology
- Cell Biology
- Gene Therapy
Background:
- Genetically modified fibroblasts (GMFb) are being explored for in vivo gene therapy.
- Understanding factors influencing GMFb survival and transgene expression is crucial for therapeutic success.
Purpose of the Study:
- To review the current understanding of GMFb biology, survival, and transgene expression in vivo.
- To identify key elements that enhance GMFb performance for gene therapy.
Main Methods:
- Review of experimental data on GMFb behavior in vivo.
- Analysis of factors influencing fibroblast survival and gene expression.
Main Results:
- Three key elements enhance GMFb survival and expression: matrix scaffolding, extracellular matrix incorporation, and use of immortalized fibroblasts.
- These modifications improve the efficacy of GMFb for in vivo applications.
Conclusions:
- Optimizing GMFb constructs with scaffolding and extracellular matrix components is vital.
- Immortalized fibroblasts offer a robust platform for gene delivery.
- Despite the invasive nature, GMFb hold significant potential for various clinical gene therapy settings.